| NAME | : | Belinostat |
| BOBOT | : | 318.35 |
| RUMUS | : | C15H14N2O4S |
| THERAPEUTIC INDC | : | Belinostat is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) with manageable safety profile.... |
| CATEGORIES | : | Antineoplastic Agents / Histone Deacetylase Inhibitors |
| STRUCTURE | : |  |